Data gathering is not a problem in COVID-19 race towards a reliable vaccine. The challenge is how to evaluate it, says Glen de Vries, Co-Founder and Co-CEO of Medidata. End of July Medidata started working with Moderna to support clinical trials of mRNA-1273, Moderna’s COVID-19 vaccine candidate.
Read More